Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial



Lotery, Andrew, Sivaprasad, Sobha, O'Connell, Abby, Harris, Rosie A, Culliford, Lucy, Ellis, Lucy, Cree, Angela, Madhusudhan, Savita, Behar-Cohen, Francine, Chakravarthy, Usha
et al (show 4 more authors) (2020) Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial. LANCET, 395 (10220). 294 - 303.

[img] Text
LoteryLancet2020.pdf - OA Published Version

Download (922kB) | Preview
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 14 Sep 2020 08:34
Last Modified: 10 Sep 2022 07:10
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3100912